Ziobro News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Ziobro. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Ziobro Today - Breaking & Trending Today

PepGen Shares Tumble 18.4% After FDA Issues Hold Notice on Study

By Paul Ziobro

PepGen shares plunged in after-hours trading Tuesday after the biotechnology company said the U.S. Food and Drug Administration issued a clinical hold notice for the study of a. | May 30, 2023 ....

United States , James Mcarthur , Paul Ziobro , Drug Administration , Gen Chief Executive James Mcarthur , Dow Jones , Pepgen Inc Stock Exchange , Press Release , F Pepg Us7133171055 ,

Workday Swings to Slight 1Q Profit, Revenue Up 17%

By Paul Ziobro

Workday on Thursday said it swung to a slight first-quarter profit as double-digit revenue growth out paced rising costs.

The Pleasanton, Calif.-based developer of cloud. | May 25, 2023 ....

Paul Ziobro , Aneel Bhusri , Chief Executive Aneel Bhusri , Dow Jones , Workday Inc Stock Exchange , Press Release , F Wday Us98138h1014 ,

Workday Shares Gain 8.3% After 1Q Earnings Beat

By Paul Ziobro

Shares of Workday rose late Thursday after the cloud software company posted better-than-expected first-quarter results and improved its outlook.

The stock rose 8.3% to. | May 25, 2023 ....

Paul Ziobro , Wall Street , Dow Jones , Workday Inc Stock Exchange , Press Release , Ose Wday Us98138h1014 ,

Northrop Grumman Boosts Quarterly Dividend by 8%

By Paul Ziobro

Northrop Grumman said Tuesday that it has raised its quarterly dividend by 8%.

The aerospace and defense company said its board of directors declared a quarterly dividend of. | May 16, 2023 ....

Paul Ziobro , Northrop Grumman , Executive Kathy Warden , Dow Jones , Northrop Grumman Corporation Stock Exchange , Press Release , Ividend Noc Us6668071029 ,

Vertex Pharmaceuticals 1Q Net Down On Higher Costs

By Paul Ziobro

Vertex Pharmaceuticals on Monday said first-quarter profit fell as higher expenses tied to drug development and international launches offset increased revenue from its cystic. | May 1, 2023 ....

United States , Paul Ziobro , Vertex Pharmaceuticals On , Dow Jones , Vertex Pharmaceuticals Incorporated Stock Exchange , Press Release , Ts Vrtx Us92532f1003 ,